INTERNATIONAL PATENT: XENCOR, INC., JANSSEN BIOTECH, INC., VLOEMANS, NELE, CORNELISSEN, IVO FILES APPLICATION FOR "ANTI-CD20 X ANTI-CD28 COMBINATION THERAPIES"

GENEVA, March 10 -- XENCOR, INC. (465 North Halstead Street, Suite 200Pasadena, CA 91107), JANSSEN BIOTECH, INC. (800/850 Ridgeview DriveHorsham, PA 19044), VLOEMANS, Nele (c/o Janssen Biotech, Inc.800/850 Ridgeview DriveHorsham, PA 19044), CORNELISSEN, Ivo (c/o Janssen Biotech, Inc.800/850 Ridgeview DriveHorsham, PA 19044) filed a patent application (PCT/US2024/044238) for "ANTI-CD20 X ANTI-CD28 COMBINATION THERAPIES" on Aug 28, 2024. With publication no. WO/2025/049613, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MO...